Home MolMed TK therapy submitted for Conditional Marketing Authorisation in EU
 

Keywords :   


MolMed TK therapy submitted for Conditional Marketing Authorisation in EU

2014-03-13 21:03:04| Logistics - Topix.net

MolMed S.p.A. announces that the Company has filed to the European Medicines Agency an application for Conditional Marketing Authorisation for TK, its novel investigational cell-gene therapy.

Tags: in marketing submitted therapy

Category:Transportation and Logistics

Latest from this category

All news

27.11Atlantic Tropical Weather Outlook
27.11Eastern North Pacific Tropical Weather Outlook
27.11Eastern North Pacific Tropical Weather Outlook
27.11Atlantic Tropical Weather Outlook
27.11Atlantic Tropical Weather Outlook
27.11Eastern North Pacific Tropical Weather Outlook
26.11Atlantic Tropical Weather Outlook
26.11Eastern North Pacific Tropical Weather Outlook
Transportation and Logistics »
27.113Q3
27.113DS 52
27.11
27.11Xotic Effects BB+ Plus
27.11
27.11 J. Lindeberg SS /
27.11
27.11DX
More »